a prospective, randomized, controlled trial of high and low doses of magnesium sulfate for acute tocolysis

Authors

vida behrad from thedepartment of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran

nezhat moosavifar the dept. of obstetrics and gynecology, imam reza hospital, mashhad university ofmedical sciences, mashhad

mojtaba mojtahedzadeh from thedepartment of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran

habid-ollah esmaili the department of community-medical & public health, ghaemhospital, mashhad university of medical sciences, mashhad, iran.

abstract

at the present, many drugs are used for inhibition of uterine contractions, but the proportions of preterm labors are increasing. although magnesium sulfate is the most commonly prescribed parenteral tocolytic agent, but its optimal use has yet to be delineated. in this study a high-dose protocol for magnesium sulfate tocolytic therapy was compared with a low-dose regimen. one-hundred patients admitted to the labor unit of imam reza&apos;s hospital with preterm labor were enrolled in the trial. the median times to successful tocolysis were 8 hours in the low-dose group and 4 hours in the high-dose group (p<0.001). patients treated with higher doses were also more likely to spend significantly less time in the labor and delivery unit (p<0.001). the median gestational age at delivery was 33 weeks in the low-dose group and 36 weeks in the high-dose group (p=o.oo l). there were not any statistically significant differences between the two groups with respect to pre- and post magnesium infusion side effects. these results suggest that in the high-dose group, tocolysis was achieved more rapidly and patients required shorter admissions to the labor and delivery unit without increased maternal or neonatal morbidity.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

A PROSPECTIVE, RANDOMIZED, CONTROLLED TRIAL OF HIGH AND LOW DOSES OF MAGNESIUM SULFATE FOR ACUTE TOCOLYSIS

At the present, many drugs are used for inhibition of uterine contractions, but the proportions of preterm labors are increasing. Although magnesium sulfate is the most commonly prescribed parenteral tocolytic agent, but its optimal use has yet to be delineated. In this study a high-dose protocol for magnesium sulfate tocolytic therapy was compared with a low-dose regimen. One-hundred patie...

full text

The Effect of Intravenous Magnesium Sulfate in Improvement of Acute Ischemic Stroke Induced Disability: A Randomized Double Blinded Clinical Trial

Background: Stroke is the third main cause of death and chronic disabilities in adults, which requires finding neuroprotective drugs to reduce its mortality and morbidity.  Objectives: To determine the efficacy of magnesium sulfate as an adjunctive neuroprotective agent in patients with stroke. Materials & Methods: This randomized double-blind clinical trial recruited 120 patients with acute ...

full text

Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.

BACKGROUND AND PURPOSE Magnesium reverses cerebral vasospasm and reduces infarct volume after experimental subarachnoid hemorrhage (SAH) in rats. We aimed to assess whether magnesium reduces the frequency of delayed cerebral ischemia (DCI) in patients with aneurysmal SAH. METHODS Patients were randomized within 4 days after SAH. Magnesium sulfate therapy consisted of a continuous intravenous ...

full text

Magnesium Sulfate in Aneurysmal Subarachnoid Hemorrhage A Randomized Controlled Trial

Background and Purpose—Magnesium reverses cerebral vasospasm and reduces infarct volume after experimental subarachnoid hemorrhage (SAH) in rats. We aimed to assess whether magnesium reduces the frequency of delayed cerebral ischemia (DCI) in patients with aneurysmal SAH. Methods—Patients were randomized within 4 days after SAH. Magnesium sulfate therapy consisted of a continuous intravenous do...

full text

IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial.

BACKGROUND Studies of IV magnesium sulfate as a treatment for acute asthma have had mixed results, with some data suggesting a benefit for acute severe asthma, but not for mild-to-moderate asthma. In a multicenter cohort, this study tests the hypothesis that administration of magnesium sulfate improves pulmonary function in patients with acute severe asthma. DESIGN Placebo-controlled, double-...

full text

My Resources

Save resource for easier access later


Journal title:
medical journal of islamic republic of iran

جلد ۱۷، شماره ۳، صفحات ۲۳۳-۲۳۸

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023